Results 121 to 130 of about 1,255 (196)

Illegal interlocks among life science company boards of directors. [PDF]

J Law Biosci
Manjunath A, Kahrobai N, Lemley MA, Kumar I.   +3 more
europepmc   +1 more source

A Competition Perspective on Physician Non-compete Agreements. [PDF]

Inquiry
Gilman DJ.
europepmc   +1 more source

The impacts of pricing and reimbursement policies on access to cell and gene therapies across Europe. [PDF]

J Community Genet
Han Y, Andreoletti M, Minssen T, Vayena E, Ormond KE.   +4 more
europepmc   +1 more source

Balancing Scientific and Commercial Interests: The European Health Data Space Response to Commercial Scientific Research. [PDF]

Inquiry
Yao X, Sun Z, Man H.
europepmc   +1 more source

Antitrust Law Focus of Second Annual State Society Meeting. [PDF]

J Oncol Pract, 2006
europepmc   +1 more source

It is time for a more nuanced discussion about pharmacy benefit managers. [PDF]

J Manag Care Spec Pharm
Cantrell SA.
europepmc   +1 more source

Transforming the Indian Private Sector for Universal Health Coverage. [PDF]

Healthcare (Basel)
Mor N.
europepmc   +1 more source

Organizational Forms and Welfare Coalitions: Corporate Law and the Movement for Social Insurance in the US and UK. [PDF]

Br J Sociol
Adereth M.
europepmc   +1 more source